Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Exosomes
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Exosomes

[0322-EXOQ20A-1] ExoQuick exosome precipitation solution - 20 mL
ExoQuick exosome precipitation solution - 20 mL
1,719.00 € 1719.0 EUR
[0322-EXOTC50A-1] ExoQuick TC (exosome isolation from tissue culture Medium) - 50 mL
ExoQuick TC (exosome isolation from tissue culture Medium) - 50 mL
1,773.50 € 1773.5 EUR
[0322-EXOTC10A-1] ExoQuick TC (exosome isolation from tissue culture Medium) - 10 mL
ExoQuick TC (exosome isolation from tissue culture Medium) - 10 mL
521.00 € 521.0 EUR
[0322-EXOQ5TM-1] ExoQuick Plasma prep and Exosome precipitation Test (5 ml ExoQuick plus 500 ul Thrombin at 500U/mL) - 75 Reactions
ExoQuick Plasma prep and Exosome precipitation Test (5 ml ExoQuick plus 500 ul Thrombin at 500U/mL) - 75 Reactions
1,210.00 € 1210.0 EUR
[0322-EQPL10A-1] ExoQuick PLUS Exosome Purification Test - for serum and plasma, 10rxn
ExoQuick PLUS Exosome Purification Test - for serum and plasma, 10rxn
783.00 € 783.0 EUR
[0322-EXFT20A-1] Exo-Fect Exosome Transfection Test, 20 reactions
Exo-Fect Exosome Transfection Test, 20 reactions
780.00 € 780.0 EUR
[0322-EXORAY200B-4] Exo-Check Exosome Antibody Array-4 arrays
Exo-Check Exosome Antibody Array-4 arrays
840.00 € 840.0 EUR
[0322-EXORAY200B-8] Exo-Check Exosome Antibody Array -8 Arrays
Exo-Check Exosome Antibody Array -8 Arrays
1,200.00 € 1200.0 EUR
[0322-EXORAY210B-4] Exo-Check Exosome Antibody Array -4 Arrays
Exo-Check Exosome Antibody Array -4 Arrays
793.00 € 793.0 EUR
[0322-EXORAY210B-8] Exo-Check Exosome Antibody Array - 8 Arrays
Exo-Check Exosome Antibody Array - 8 Arrays
1,088.00 € 1088.0 EUR
[0322-EXOCET96A-1] EXOCET Exosome Quantitation Test - 96 reactions
EXOCET Exosome Quantitation Test - 96 reactions
708.50 € 708.5 EUR
[0322-EVEN110A-1] EV-Entry System for Exosome Delivery (10 rxn) - 10 reactions
EV-Entry System for Exosome Delivery (10 rxn) - 10 reactions
715.00 € 715.0 EUR
[0322-EVS105A-1] EV Shuttle Test Human HEK293 cell exosomes (5 rxn)
EV Shuttle Test Human HEK293 cell exosomes (5 rxn)
777.00 € 777.0 EUR
[0568-P201] Detergent-free Exosomal Protein Extraction Test, 10rxn
Detergent-free Exosomal Protein Extraction Test, 10rxn
833.30 € 833.3000000000001 EUR
[0481-HBM-DAUDI-100] Lyophilized exosomes from DAUDI cell culture supernatant
Lyophilized exosomes from DAUDI cell culture supernatant
940.00 € 940.0 EUR
[0501-Exo-CH14] QExo Exosome-SK-N-SH - 1 vial/(> 1x10^8 Particle
QExo Exosome-SK-N-SH - 1 vial/(> 1x10^8 Particle
1,970.00 € 1970.0 EUR
[0322-EXOP-500A-1] Purified Exosomes from Human Serum (Healthy Donors) - >25ug.
Purified Exosomes from Human Serum (Healthy Donors) - >25ug.
778.00 € 778.0 EUR
[0501-Kit-1108-100 Tests] Overall Exosome Capture and Quantification Assay Test (Cell Medium, Colorimetric) - 100 tests
Overall Exosome Capture and Quantification Assay Test (Cell Medium, Colorimetric) - 100 tests
2,700.00 € 2700.0 EUR
[0900-TBS2105] β-Hexosaminidase Activity Assay, 100 tests
β-Hexosaminidase Activity Assay, 100 tests
450.00 € 450.0 EUR
[0322-CYTO122-VA-1] pCT-CD9-GFP (pCMV, Exosome/Secretory, CD9 Tetraspanin Tag) - >2x10^6 IFUs
pCT-CD9-GFP (pCMV, Exosome/Secretory, CD9 Tetraspanin Tag) - >2x10^6 IFUs
1,220.00 € 1220.0 EUR
  • 1
  • 2
  • 3

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)